Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Sophiris Bio Inc SPHS

Healthcare Biotechnology
Sophiris Bio Inc is a clinical-stage biopharmaceutical company. It focuses on the development of products for the treatment of urological diseases. The company's product portfolio includes topsalysin (PRX302), for the treatment of lower urinary tract symptoms of benign prostatic hyperplasia (BPH), as well as for the treatment of localized low to intermediate risk prostate cancer. Topsalysin is... see more

Bullboard (EXPM:SPHS)

View:
Post by Chrysler_Kidon Apr 01, 2022 12:04pm

OTC

Whose paying the annual fee to keep this stock listed and why?
74
Post by melaurianon Dec 14, 2020 11:09am

First hand experience with prostate cancer.

$SPHS Season's Greetings! Last year I was diagnosed with prostate cancer and my PSA reading was 6.0. In June 2020 my PSA went down to 5.5. I just heard from my Urologist today and found out that ...more  
104
Comment by nugieon Aug 29, 2018 1:53pm

RE:Very good news today: patient death likely unrelated.

About ime we got SOME good news! Bin in this for years since it was Protox!
178
Discussion
Post by melaurianon Aug 29, 2018 8:52am

Very good news today: patient death likely unrelated.

August 29, 2018 https://sphs2017.wordpress.com
205
Discussion
Comment by melaurianon Jun 10, 2018 3:22pm

RE:New High

-I'm looking for new all time highs this year. Of course we will see how things play out. However top line trial results could be met with partnership/takeover offers. We shall see what we shall ...more  
263
Discussion
Post by 2bewildon May 31, 2018 12:28pm

New High

Will July 26,2018 test the old high of $8.55 on July 26,2016? Coincides with good news/results at the end of Q2.
247
Discussion
Comment by melaurianon May 19, 2018 11:09am

RE:Useful Data and Articles

A six-month data read-out on 38 patients currently enrolled in a PH2b prostate cancer trial is due around the end of the 2nd quarter. Some of these patients may opt for a second dose of Topsalysin ...more  
188
Discussion
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities